Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pharmacological Research

• Publication date

  2011-09-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1016/j.phrs.2011.04.010PMID 21600985PMCID PMC3140828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erratum to: Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat

  2011cited by this paper
• Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain

  2011cited by this paper
• Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.

  2011cited by this paper
• Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.

  2010cited by this paper
• Early life influences on emotional reactivity: evidence that social enrichment has greater effects than handling on anxiety-like behaviors, neuroendocrine responses to stress and central BDNF levels.

  2010cited by this paper
• Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition

  2010cited by this paper
• Endogenous cannabinoid signaling is essential for stress adaptation

  2010cited by this paper
• FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.

  2010cited by this paper
• Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system

  2010cited by this paper
• Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus.

  2010cited by this paper
• Motion Sickness, Stress and the Endocannabinoid System

  2010cited by this paper
• Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.

  2010cited by this paper
• Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats.

  2010cited by this paper
• A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.

  2010cited by this paper
• An endocannabinoid signal associated with desire for alcohol is suppressed in recently abstinent alcoholics

  2009cited by this paper
• The endocannabinoid system and the treatment of mood and anxiety disorders.

  2009cited by this paper
• Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

  2009cited by this paper
• The role of prefrontal cortex CB1 receptors in the modulation of fear memory.

  2009cited by this paper
• Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function.

  2009cited by this paper
• Circulating endocannabinoid concentrations during orthostatic stress

  2009cited by this paper
• Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic-Pituitary-Adrenal Axis

  2009cited by this paper
• Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice

  2009cited by this paper
• Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism.

  2009cited by this paper
• Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression.

  2009cited by this paper
• The future of endocannabinoid-oriented clinical research after CB1 antagonists

  2009cited by this paper
• Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats

  2009influential reference
• Blockade of Endocannabinoid-Degrading Enzymes Attenuates Neuropathic Pain

  2009cited by this paper
• Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo

  2009cited by this paper
• Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.

  2009cited by this paper
• Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours.

  2009cited by this paper
• Gender‐dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: A possible role for the endocannabinoid system

  2008cited by this paper
• Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.

  2008cited by this paper
• Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?

  2008cited by this paper
• Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders.

  2008cited by this paper
• Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex.

  2008cited by this paper
• Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat

  2008cited by this paper
• Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.

  2008cited by this paper
• Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus

  2008cited by this paper
• Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

  2008cited by this paper
• Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.

  2008cited by this paper
• Cat odour-induced anxiety—a study of the involvement of the endocannabinoid system

  2008cited by this paper
• Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice.

  2008cited by this paper
• The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.

  2008cited by this paper
• Endocannabinoid System and Synaptic Plasticity: Implications for Emotional Responses

  2007cited by this paper
• Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission

  2007cited by this paper
• overweight: updated meta-analysis Long term pharmacotherapy for obesity and

  2007cited by this paper
• A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol

  2007cited by this paper
• Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats

  2007cited by this paper
• Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.

  2007cited by this paper
• Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality

  2007cited by this paper
• Long term pharmacotherapy for obesity and overweight: updated meta-analysis

  2007cited by this paper
• Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling

  2006cited by this paper
• Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597).

  2006cited by this paper
• Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress

  2005cited by this paper
• Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.

  2005cited by this paper
• Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands

  2005cited by this paper
• Structure and function of fatty acid amide hydrolase.

  2005cited by this paper
• An endocannabinoid mechanism for stress-induced analgesia

  2005influential reference
• Inhibition of restraint stress‐induced neural and behavioural activation by endogenous cannabinoid signalling

  2005cited by this paper
• Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons.

  2005cited by this paper
• Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice

  2005cited by this paper
• CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

  2004cited by this paper
• Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis.

  2004cited by this paper
• Cautionary Note on Reporting Eta-Squared Values from Multifactor ANOVA Designs

  2004cited by this paper
• RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol

  2004cited by this paper
• Context‐dependent effects of CB1 cannabinoid gene disruption on anxiety‐like and social behaviour in mice

  2004cited by this paper
• Modulation of anxiety through blockade of anandamide hydrolysis

  2003cited by this paper
• Brain monoglyceride lipase participating in endocannabinoid inactivation

  2002cited by this paper
• The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety

  2002cited by this paper
• A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam

  2002cited by this paper
• Eta Squared, Partial Eta Squared, and Misreporting of Effect Size in Communication Research

  2002cited by this paper
• SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.

  2001cited by this paper
• Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters.

  2001cited by this paper
• Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase

  2001cited by this paper
• SL651498: An Anxioselective Compound with Functional Selectivity for α2- and α3-Containing γ-Aminobutyric AcidA (GABAA) Receptors

  2001cited by this paper
• Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety‐like responses in the rat

  1997cited by this paper
• Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects

  1996cited by this paper
• Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

  1996cited by this paper
• Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.

  1991cited by this paper
• Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

  1985cited by this paper

• Differential effects of adolescent fatty acid amide hydrolase and monoacylglycerol lipase inhibition on adolescent and adult behaviors in male rats.

  2026cites this paper
• Effects of fecal microbiota transplantation from patients with generalized anxiety on anxiety-like behaviors: The role of the gut-microbiota-endocannabinoid-brain Axis.

  2025cites this paper
• Endocannabinoid response to social stress in chronic non-medical prescription opioid users

  2025cites this paper
• Inhibition of an Endocannabinoid Catabolizing Enzyme is a Potential Mechanism for the Anxiolytic Effect of Chamomile.

  2025cites this paper
• The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles

  2025cites this paper
• The Effects of Indirect and Direct Modulation of Endocannabinoid System Function on Anxiety-Related Behavior in Mice Assessed in the Elevated Plus Maze Test

  2025cites this paper
• Stress reactivity is modulated by cannabinoid type-1 receptors in norepinephrine and epinephrine neurons in a context-dependent manner.

  2025cites this paper
• Differential Effects of Adolescent Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibition on Adolescent and Adult Behaviors in Male Rats

  2025cites this paper
• Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation

  2025cites this paper
• Fluoxetine Modulates Both Endocannabinoid and Lysophosphatidic Acid Pathways in a Region-Specific Manner During Alcohol Withdrawal in Male Rats.

  2025cites this paper
• Neurolipidomic Insights into Anxiety Disorders: Uncovering Lipid Dynamics for Potential Therapeutic Advances.

  2024cites this paper
• Pleasant Odor Decreases Mouse Anxiety-like Behaviors by Regulating Hippocampal Endocannabinoid Signaling

  2024cites this paper
• The endocannabinoid 2-arachidonoylglycerol is released and transported on demand via extracellular microvesicles

  2024cites this paper
• The Estrous Cycle Influences the Effects of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibition in the Anxiety-Like Behavior in Rats

  2023influential citation
• The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses

  2023cites this paper
• Repeated Mild Traumatic Brain Injury and JZL184 Produce Sex-Specific Increases in Anxiety-Like Behavior and Alcohol Consumption in Wistar Rats

  2023cites this paper
• Cannabinoids: Emerging sleep modulator.

  2023cites this paper
• JZL184 increases anxiety-like behavior and does not reduce alcohol consumption in female rats after repeated mild traumatic brain injury

  2023influential citation
• Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective

  2023cites this paper
• The role of the endocannabinoid 2-arachidonoylglycerol in the in vivo spinal oxytocin-induced antinociception in male rats.

  2023cites this paper
• Anxiety Modulation by Cannabinoids—The Role of Stress Responses and Coping

  2023cites this paper
• Endocannabinoid system reactivity during stress processing in healthy humans.

  2022cites this paper
• The Endocannabinoid 2-Arachidonoylglycerol Bidirectionally Modulates Acute and Protracted Effects of Predator Odor Exposure.

  2022cites this paper
• Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond.

  2022cites this paper
• Neuropsychopharmacological profiling of scoparone in mice

  2022cites this paper
• Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes

  2022cites this paper
• Lipid endocannabinoids in energy metabolism, stress and developmental programming.

  2021cites this paper
• Attenuation of fearconditioned analgesia in rats by lipase inhibition in the anterior Potential role for CB2 receptors

  2021cites this paper
• Regulation of stress-provoked aggressive behavior using endocannabinoids

  2021cites this paper
• Lipids | The Endocannabinoid System

  2021cites this paper
• Comorbid anxiety-like behavior in a rat model of colitis is mediated by an upregulation of corticolimbic fatty acid amide hydrolase

  2021cites this paper
• Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors

  2021cites this paper
• Cannabis use and posttraumatic stress disorder comorbidity: Epidemiology, biology and the potential for novel treatment approaches.

  2021cites this paper
• Endocannabinoids, Cannabinoids and the Regulation of Anxiety.

  2021cites this paper
• Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid

  2021cites this paper
• The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

  2021cites this paper
• Dual Inhibition of FAAH and MAGL Counteracts Migraine-like Pain and Behavior in an Animal Model of Migraine

  2021cites this paper
• Anxiety

  2021cites this paper
• On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence

  2021cites this paper
• Untapped endocannabinoid pharmacological targets: pipe dream or pipeline?

  2021cites this paper
• Endocannabinoid Gene × Gene Interaction Association to Alcohol Use Disorder in Two Adolescent Cohorts

  2021cites this paper
• Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors.

  2020cites this paper
• Cannabinoid CB2 receptors mediate the anxiolytic-like effects of monoacylglycerol lipase inhibition in a rat model of predator-induced fear

  2020cites this paper
• The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors.

  2020cites this paper
• Endocannabinoid System Components as Potential Biomarkers in Psychiatry

  2020cites this paper
• Endocannabinoid Signaling Collapse Mediates Stress-Induced Amygdalo-Cortical Strengthening.

  2020cites this paper
• Endocannabinoid signaling and stress resilience

  2020cites this paper
• A systematic, integrative review of the effects of the endocannabinoid system on inflammation and neurogenesis in animal models of affective disorders.

  2020cites this paper
• 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics.

  2020cites this paper
• Attenuation of fear‐conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: Potential role for CB2 receptors

  2020cites this paper
• Monoacylglycerol lipase alpha inhibition alters prefrontal cortex excitability and blunts the consequences of traumatic stress in rat.

  2020cites this paper
• Druggable Targets of the Endocannabinoid System: Implications for the Treatment of HIV-Associated Neurocognitive Disorder.

  2019cites this paper
• Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks

  2019cites this paper
• The endocannabinoid system: from the receptors to therapy

  2019cites this paper
• The role of the endocannabinoid system in the emotional modulation of pain

  2018influential citation
• Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake

  2018cites this paper
• Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors

  2018cites this paper
• Enhanced endocannabinoid tone as a potential target of pharmacotherapy

  2018cites this paper
• 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain.

  2018cites this paper
• Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder

  2018cites this paper
• Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy

  2018cites this paper
• Monoacylglycerol lipase (MAGL) as a promising therapeutic target.

  2018cites this paper
• Inhibition of Diacylglycerol Lipase Impairs Fear Extinction in Mice

  2018cites this paper
• Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains

  2018cites this paper
• Sex-dependent effects of in utero cannabinoid exposure on cortical function

  2018cites this paper
• Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence

  2018cites this paper
• Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke

  2018cites this paper
• ENDOCANNABINOID REGULATION OF ADOLESCENT DEVELOPMENT IN MALE AND FEMALE RATS

  2018cites this paper
• Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the Modulation of Anxiety.

  2017cites this paper
• 2-Arachidonoylglycerol endocannabinoid signaling coupled to metabotropic glutamate receptor type-5 modulates anxiety-like behavior in the rat ventromedial prefrontal cortex

  2017cites this paper
• The Endocannabinoid System and Anxiety.

  2017cites this paper
• Genome-wide expression and response to exposure-based psychological therapy for anxiety disorders

  2017cites this paper
• Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats

  2017cites this paper
• The CB1 Receptor as the Cornerstone of Exostasis.

  2017cites this paper
• Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake

  2017cites this paper
• The Endocannabinoid, 2-arachidonoylglycerol, Regulates Resilience to Stress-induced Anxiety

  2017influential citation
• The endocannabinoid system as a target for novel anxiolytic drugs.

  2017cites this paper
• Endocannabinoid signalling modulates susceptibility to traumatic stress exposure

  2017cites this paper
• Endocannabinoid Turnover.

  2017cites this paper
• From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.

  2016cites this paper
• 2-arachidonoylglycerol signaling impairs short-term fear extinction

  2016cites this paper
• Neurobiological Interactions Between Stress and the Endocannabinoid System

  2016cites this paper
• Monoglyceride lipase: Structure and inhibitors.

  2016cites this paper
• Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases.

  2016cites this paper
• Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats

  2016cites this paper
• Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety.

  2016cites this paper
• Endocannabinoid augmentation through substrate-selective COX-2 inhibition: Behavioral and synaptic effects in an animal model of stress-induced anxiety

  2016cites this paper
• Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.

  2016cites this paper
• Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey.

  2016influential citation
• Developmental regulation of fear learning and anxiety behavior by endocannabinoids

  2016cites this paper
• Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses

  2016cites this paper
• Endocannabinoids and Mental Disorders.

  2015cites this paper
• Full FAAH inhibition combined with partial monoacylglycerol lipase inhibition: Augmented and sustained antinociceptive effects with reduced cannabimimetic side effects in mice

  2015cites this paper
• Endocannabinoids and related lipids in blood plasma following touch massage: a randomised, crossover study

  2015cites this paper
• Development of an HPLC/UV assay for the evaluation of inhibitors of human recombinant monoacylglycerol lipase.

  2015cites this paper
• Roles and Actions of Arachidonic Acid-Derived Bioactive Lipids in Stress-Related Behaviors

  2015cites this paper
• The potential of inhibitors of endocannabinoid metabolism as anxiolytic and antidepressive drugs--A practical view.

  2015cites this paper
• Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents

  2015cites this paper
• Integrating Chemoproteomic and Metabolomic Platforms for Target Identification and Toxicological Assessment of Environmental Chemicals

  2015cites this paper
• The endocannabinoid system in guarding against fear, anxiety and stress

  2015cites this paper